Stabilized GHRH(1-44) analog with trans-3-hexenoic acid N-terminal modification. Precursor for visceral adiposity and somatotropic axis research; closely related to tesamorelin class.
Tesam is a stabilized GHRH analog bearing a trans-3-hexenoic acid N-terminal modification that confers resistance to dipeptidyl peptidase IV (DPP-IV) cleavage, the primary in vivo degradation pathway for native GHRH. Tesam is closely related to Tesamorelin and serves as a research tool for studying the GHRH receptor (GHRHR) signaling axis, somatotrope function, and visceral adiposity regulation in preclinical metabolic models.
HPLC >=99%; LC-MS confirmed; endotoxin tested. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | Tesam |
| CAS Number | 218949-48-9 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 4,887.47 g/mol |
| Molecular Formula | C221H363N65O63S2 |
| Appearance | White lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 10mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.